Literature DB >> 12122733

Inflammatory bowel disease and environmental influences.

Aruna Krishnan1, Joshua R Korzenik.   

Abstract

Some environmental factors have been established firmly as influences on the development of IBD, such as smoking and appendectomy. Other behaviors, such as oral contraceptive use and sugar intake, have been suggested as risk factors, but he data conflict sharply. The importance of other behaviors, such as breast-feeding, is even murkier with sharply divergent data. Some issues studied may not be factors in themselves but rather markers for other unidentified influences. The conflicting evidence in many of these studies may be clarified as specific genes are identified and the interplay between these environmental factors and genetic subtypes is investigated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12122733     DOI: 10.1016/s0889-8553(01)00003-6

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  9 in total

1.  Inflammatory bowel disease: reviewing an old study under a new perspective.

Authors:  Constantinos C Frangos; Christos C Frangos
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

2.  Effects of surgery on peripheral N-terminal propeptide of type III procollagen in patients with Crohn's disease.

Authors:  Matilde De Simone; Michele M Ciulla; Ugo Cioffi; Luca Poggi; Barbara Oreggia; Roberta Paliotti; Fiorenzo Botti; Alberto Carrara; Fiorenza Agosti; Alessandro Sartorio; Ettore Contessini-Avesani
Journal:  J Gastrointest Surg       Date:  2007-08-09       Impact factor: 3.452

Review 3.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

4.  Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides.

Authors:  Amosy E M'Koma; Erin H Seeley; Mary K Washington; David A Schwartz; Roberta L Muldoon; Alan J Herline; Paul E Wise; Richard M Caprioli
Journal:  Inflamm Bowel Dis       Date:  2010-08-30       Impact factor: 5.325

5.  Immunomodulation does not alter histology in resected Crohn's disease.

Authors:  F A Frizelle; A Ing; R B Gearry; M Whitehead; I G Faragher; B Dobbs
Journal:  Tech Coloproctol       Date:  2009-09-23       Impact factor: 3.781

6.  Passive smoking and inflammatory bowel disease: a meta-analysis.

Authors:  Deborah T Jones; Mark T Osterman; Meenakshi Bewtra; James D Lewis
Journal:  Am J Gastroenterol       Date:  2008-09       Impact factor: 10.864

7.  Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery.

Authors:  Matilde De Simone; Ugo Cioffi; Ettore Contessini-Avesani; Barbara Oreggia; Roberta Paliotti; Alberto Pierini; Gianni Bolla; Elide Oggiano; Stefano Ferrero; Fabio Magrini; Michele M Ciulla
Journal:  BMC Gastroenterol       Date:  2004-11-04       Impact factor: 3.067

Review 8.  Epidemiology of intrafamilial inflammatory bowel disease throughout Europe.

Authors:  Maria Teresa Arias-Loste; Beatriz Castro; Montserrat Rivero; Javier Crespo
Journal:  Ann Gastroenterol       Date:  2012

9.  Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis.

Authors:  Katsuyuki Fukuda; Yoshiyuki Fujita
Journal:  BMC Gastroenterol       Date:  2014-03-19       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.